Cerebral sinovenous thrombosis [2] (multiple letters)

New England Journal of Medicine

Volumn 345, Issue 24, 2001, Pages 1777-1778

  Meyer, Michael Andrew ^a   DeVeber, Gabrielle ^a   David, Michele ^a   Mitchell, Lesley ^a  

^a DENT NEUROLOGIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

BRAIN PERFUSION; CEREBRAL SINUS THROMBOSIS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FIBRINOLYTIC THERAPY; HEMOSTASIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEUROLOGIC EXAMINATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SAGITTAL SINUS THROMBOSIS; TREATMENT OUTCOME;

ADULT; CHILD; HUMANS; INFUSIONS, INTRAVENOUS; PLASMINOGEN ACTIVATORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035857153     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200112133452414     Document Type: Letter

References (0)